| Year |
Citation |
Score |
| 2019 |
Morrissey I, Olesky M, Hawser S, Lob SH, Karlowsky JA, Corey GR, Bassetti M, Fyfe C. Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017. Antimicrobial Agents and Chemotherapy. PMID 31843999 DOI: 10.1128/Aac.01699-19 |
0.434 |
|
| 2019 |
Seifert H, Stefanik D, Olesky M, Higgins PG. In-vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii. International Journal of Antimicrobial Agents. PMID 31669740 DOI: 10.1016/j.ijantimicag.2019.10.010 |
0.376 |
|
| 2019 |
Solomkin JS, Sway A, Lawrence K, Olesky M, Izmailyan S, Tsai L. Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance. Future Microbiology. PMID 31570004 DOI: 10.2217/Fmb-2019-0135 |
0.402 |
|
| 2019 |
Gupta V, Ye G, Olesky M, Lawrence K, Murray J, Yu K. Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017. Bmc Infectious Diseases. 19: 742. PMID 31443635 DOI: 10.1186/S12879-019-4387-3 |
0.442 |
|
| 2019 |
Gupta V, Ye G, Olesky M, Lawrence K, Murray J, Yu K. National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 31229615 DOI: 10.1016/J.Ijid.2019.06.017 |
0.363 |
|
| 2019 |
Lodise T, Izmailyan S, Olesky M, Lawrence K, Tsai L. 2264. An Evaluation of Empiric Treatment Patterns for Adult Patients with Community-Onset (CO) “Low-Risk” (LR) Complicated Intra-Abdominal Infections (cIAI) Across US Hospitals Open Forum Infectious Diseases. 6: S775-S775. DOI: 10.1093/Ofid/Ofz360.1942 |
0.321 |
|
| 2019 |
Zilberberg M, Nathanson B, Lawrence K, Johnson C, Ditch K, Olesky M, Shorr AF. 2259. Predictors of Empiric Carbapenem Therapy in Complicated Intra-Abdominal Infections in the United States, 2013–2017: A Retrospective Cohort Study Open Forum Infectious Diseases. 6: S773-S773. DOI: 10.1093/Ofid/Ofz360.1937 |
0.386 |
|
| 2018 |
Tabak Y, Olesky M, Efimova E, Kurtz S, Murray J, Gupta V. 611: Multidrug-Resistant Enterobacteriaceae Infections By Pathogen And Icu Type Critical Care Medicine. 46: 292. DOI: 10.1097/01.Ccm.0000528626.50614.71 |
0.423 |
|
| 2017 |
Olesky M, Johannes R, Ye G, Tabak Y, Murray J, Gupta V. Trends in Resistant Enterobacteriaceae (ENT), Acinetobacter baumannii (ACB) and Extended Spectrum Beta-Lactamase (ESBL) Organisms in Hospitalized Patients in the US: 2011-2016 Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.253 |
0.398 |
|
| 2016 |
Hoffman-Roberts H, Olesky M, Tabak YP, Mohr J, Johannes RS, Gupta V. National Prevalence of Carbapenem-Resistant Enterobacteriaceae in the Ambulatory and Acute Care Settings in the United States in 2015 Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.216 |
0.329 |
|
| 2016 |
Bassetti M, Corey R, Doi Y, Morrissey I, Grossman T, Olesky M, Scoble P, Sutcliffe J. In Vitro Global Surveillance of Eravacycline and Comparators Against Enterobacteriaceae, Acinetobacter baumannii, Stenotrophomonas maltophilia, Including Multidrug-Resistant (MDR) Isolates, Over a 3-Year Period (2013–2015) Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1373 |
0.428 |
|
| 2006 |
Olesky M, Zhao S, Rosenberg RL, Nicholas RA. Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB proteins with penB mutations. Journal of Bacteriology. 188: 2300-8. PMID 16547016 DOI: 10.1128/Jb.188.7.2300-2308.2006 |
0.6 |
|
| 2003 |
Stefanova ME, Tomberg J, Olesky M, Höltje JV, Gutheil WG, Nicholas RA. Neisseria gonorrhoeae penicillin-binding protein 3 exhibits exceptionally high carboxypeptidase and beta-lactam binding activities. Biochemistry. 42: 14614-25. PMID 14661974 DOI: 10.1021/Bi0350607 |
0.506 |
|
| 2002 |
Olesky M, Hobbs M, Nicholas RA. Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy. 46: 2811-20. PMID 12183233 DOI: 10.1128/Aac.46.9.2811-2820.2002 |
0.612 |
|
| 2002 |
Ropp PA, Hu M, Olesky M, Nicholas RA. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy. 46: 769-77. PMID 11850260 DOI: 10.1128/Aac.46.3.769-777.2002 |
0.614 |
|
| 1998 |
Li Q, Olesky M, Palmer RK, Harden TK, Nicholas RA. Evidence that the p2y3 receptor is the avian homologue of the mammalian P2Y6 receptor. Molecular Pharmacology. 54: 541-6. PMID 9730913 DOI: 10.1124/Mol.54.3.541 |
0.434 |
|
| Show low-probability matches. |